| 9.46 Data as of May 17 |  +0.04 / +0.42%Today’s Change | 3.78 Today|||52-Week Range 10.48 | +93.06% Year-to-Date |
| Previous close | 9.42 |
| Today’s open | 9.46 |
| Day’s range | 8.79 - 9.66 |
| Volume | 1,329,144 |
| Average volume (3 months) | 276,806 |
| Market cap | $397.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -66.67% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +48.80% |
| P/E ratio | 105.1 |
| Price/Sales | 2.51 |
| Price/Book | 9.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| SSRX3SBio Inc | +0.02 | +0.12% |
| FURXFuriex Pharmaceutica... | +1.38 | +3.76% |
| TSRXTrius Therapeutics I... | +0.10 | +1.27% |
| PBTHPROLOR Biotech Inc | +0.15 | +2.37% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $81.5M |
| Annual profit (last year) | $4.8M |
| Net profit margin | 5.93% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, Chief Executive & Scientific Officer Ryuji Ueno, MD, PhD |
Chief Operating Officer James J. Egan |
Corporate headquarters Bethesda, Maryland |
.
